X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (702) 702
Publication (51) 51
Conference Proceeding (47) 47
Book Review (41) 41
Book / eBook (4) 4
Dissertation (2) 2
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (396) 396
humans (373) 373
cardiac & cardiovascular systems (359) 359
female (274) 274
male (274) 274
aged (252) 252
abridged index medicus (219) 219
middle aged (212) 212
treatment outcome (165) 165
risk factors (163) 163
atrial fibrillation (146) 146
stroke (139) 139
heart attacks (125) 125
cardiovascular (124) 124
acute coronary syndromes (121) 121
mortality (117) 117
double-blind method (106) 106
clinical trials (97) 97
drug therapy (95) 95
myocardial infarction (95) 95
peripheral vascular disease (94) 94
anticoagulants (90) 90
care and treatment (89) 89
clopidogrel (89) 89
follow-up studies (85) 85
medical and health sciences (77) 77
medicin och hälsovetenskap (77) 77
risk (77) 77
coronary heart disease (75) 75
outcomes (75) 75
cardiology (73) 73
stroke - prevention & control (72) 72
warfarin (70) 70
analysis (68) 68
prospective studies (65) 65
hemorrhage - chemically induced (64) 64
time factors (64) 64
anticoagulants - therapeutic use (62) 62
patient outcomes (62) 62
cardiac patients (61) 61
electrocardiography (61) 61
platelet aggregation inhibitors - therapeutic use (61) 61
prognosis (61) 61
atrial fibrillation - drug therapy (60) 60
therapy (59) 59
aged, 80 and over (56) 56
atrial fibrillation - complications (56) 56
cardiac arrhythmia (56) 56
cardiology and cardiovascular medicine (56) 56
heart attack (55) 55
internal medicine (55) 55
patients (55) 55
cardiovascular disease (54) 54
clinical medicine (54) 54
acute coronary syndrome - drug therapy (53) 53
aspirin (53) 53
myocardial-infarction (53) 53
stroke - etiology (53) 53
prevention (52) 52
heart failure (51) 51
management (51) 51
cardiovascular diseases (50) 50
ischemia (49) 49
percutaneous coronary intervention (49) 49
anticoagulants - administration & dosage (48) 48
anticoagulants - adverse effects (48) 48
rivaroxaban (47) 47
ticlopidine - analogs & derivatives (47) 47
acute coronary syndrome (46) 46
studies (46) 46
klinisk medicin (45) 45
proportional hazards models (45) 45
diabetes (44) 44
platelet aggregation inhibitors - adverse effects (44) 44
kardiologi (43) 43
bleeding (42) 42
cardiac and cardiovascular systems (42) 42
hemorrhage (42) 42
randomized controlled trials as topic (42) 42
medicine, general & internal (41) 41
myocardial infarction - mortality (41) 41
risk assessment (41) 41
myocardial infarction - drug therapy (40) 40
myocardial infarction - therapy (40) 40
unstable angina (40) 40
coronary vessels (39) 39
thrombosis (39) 39
acute myocardial-infarction (38) 38
dosage and administration (38) 38
hospitalization (38) 38
medical colleges (38) 38
anticoagulation (37) 37
incidence (37) 37
registries (37) 37
ticagrelor (37) 37
research (36) 36
safety (36) 36
usage (36) 36
medical research (35) 35
trial (35) 35
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Heart Journal, ISSN 0195-668X, 08/2018, Volume 39, Issue 32, pp. 2972 - 2974
Journal Article
Diabetologia, ISSN 0012-186X, 10/2019, Volume 62, Issue 10, pp. 1854 - 1867
An increased risk of fracture with canagliflozin vs placebo was reported from the CANagliflozin cardioVascular Assessment Study (CANVAS) Program, with... 
Medicine & Public Health | Human Physiology | Canagliflozin | Metabolic Diseases | Sodium glucose co-transporter 2 inhibitors | Internal Medicine | Fracture | CANVAS Program | Type 2 diabetes mellitus | Risk factors | Fractures | Diabetes | Index Medicus
Journal Article
Circulation, ISSN 0009-7322, 11/2018, Volume 138, Issue Suppl_1 Suppl 1, pp. A15123 - A15123
IntroductionIn atrial fibrillation (AF), the CHA2DS2-VASc score is widely used for risk stratification but has consistently shown modest discrimination at... 
Journal Article
Stroke, ISSN 0039-2499, 02/2019, Volume 50, Issue 2, pp. 396 - 404
BACKGROUND AND PURPOSE—This study reports the detailed effects of canagliflozin on stroke, stroke subtypes, and vascular outcomes in participants with and... 
Type 2 diabetes | Stroke (Disease) | Complications and side effects | Drug therapy | Patient outcomes | Risk factors | 10060 | ischemic attack, transient | Original Contributions | 10173 | canagliflozin | diabetes mellitus, type 2 | cardiovascular diseases | 10058 | stroke
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 7, pp. 644 - 657
In this report of two randomized trials, patients with type 2 diabetes at risk for cardiovascular disease received the sodium–glucose cotransporter 2 inhibitor... 
MEDICINE, GENERAL & INTERNAL | METAANALYSIS | ATRIAL-NATRIURETIC-PEPTIDE | RATIONALE | INTENSIVE GLUCOSE CONTROL | PLACEBO-CONTROLLED TRIAL | OUTCOMES | INHIBITORS | STAGE KIDNEY-DISEASE | PROGRESSION | BASE-LINE CHARACTERISTICS | Hypoglycemic Agents - therapeutic use | Albuminuria - complications | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Hospitalization - statistics & numerical data | Kidney Diseases - mortality | Male | Canagliflozin - adverse effects | Disease Progression | Foot - surgery | Glomerular Filtration Rate - drug effects | Diabetes Mellitus, Type 2 - physiopathology | Canagliflozin - therapeutic use | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Aged | Amputation - statistics & numerical data | Kidney Diseases - etiology | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Type 2 diabetes | Heart | Complications and side effects | Care and treatment | Abnormalities | Amputation | Myocardial infarction | Heart attacks | Body weight | Clinical trials | Cardiovascular disease | Blood pressure | Drug dosages | Heart failure | Cerebral infarction | Stroke | Statistical analysis | Kidneys | Metatarsal | Diabetes mellitus | Toe | FDA approval | Glomerular filtration rate | Medicine | Studies | Side effects | Sodium | Diabetes | Kidney diseases | Cardiovascular diseases | Health risk assessment | Kidney transplantation | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2018, Volume 379, Issue 22, pp. 2097 - 2107
Among patients who had had an acute coronary syndrome, the risk of death from coronary heart disease, nonfatal myocardial infarction, stroke, or unstable... 
MEDICINE, GENERAL & INTERNAL | MANAGEMENT | MYOCARDIAL-INFARCTION | TASK-FORCE | EFFICACY | SAFETY | LDL | REDUCING LIPIDS | PCSK9 | MONOCLONAL-ANTIBODY | ASSOCIATION | Double-Blind Method | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - blood | Acute Coronary Syndrome - drug therapy | Acute Coronary Syndrome - complications | Anticholesteremic Agents - therapeutic use | Proprotein Convertase 9 - antagonists & inhibitors | Cardiovascular Diseases - epidemiology | Adult | Cholesterol, LDL - blood | Female | Hypercholesterolemia - complications | Aged | Acute coronary syndrome | Diagnosis | Myocardial infarction | Fees & charges | Lipoproteins (low density) | Heart attacks | Lipids | Cardiovascular disease | Angina | Apolipoprotein B | Ischemia | Heart diseases | Drug dosages | Statins | Cerebral infarction | Stroke | Subtilisin | Apolipoproteins | Angina pectoris | Patients | Low density lipoprotein | Coronary artery disease | Cholesterol | Kexin | Monoclonal antibodies | Full text | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Pharmaceuticals | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 08/2016, Volume 9, Issue 16, pp. 1694 - 1702